Cereblon in health and disease

被引:36
作者
Kim, Hyoung Kyu [1 ,2 ]
Ko, Tae Hee [1 ]
Nyamaa, Bayalagmaa [1 ]
Lee, Sung Ryul [1 ,2 ]
Kim, Nari [1 ]
Ko, Kyung Soo [1 ]
Rhee, Byoung Doo [1 ]
Park, Chul-Seung [3 ,4 ]
Nilius, Bernd [5 ]
Han, Jin [1 ]
机构
[1] Inje Univ, Natl Res Lab Mitochondrial Signaling, Cardiovasc & Metab Dis Ctr, Dept Physiol,Dept Hlth Sci & Technol,Coll Med,Plu, Bokji Ro 75, Busan 47392, South Korea
[2] Inje Univ, Dept Integrated Biomed Sci, Coll Med, Busan, South Korea
[3] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju 500712, South Korea
[4] Gwangju Inst Sci & Technol, Natl Leading Res Lab Ion Channels, Gwangju 500712, South Korea
[5] Katholieke Univ Leuven, Lab Ion Channel Res, Dept Cellular & Mol Med, Leuven, Belgium
来源
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY | 2016年 / 468卷 / 08期
基金
新加坡国家研究基金会;
关键词
Cereblon; Mental retardation; BKCa; E3 ligase complex; AMPK; Immunomodulatory drugs; CHRONIC LYMPHOCYTIC-LEUKEMIA; E3 UBIQUITIN LIGASE; IDIOPATHIC GENERALIZED EPILEPSY; ENDOPLASMIC-RETICULUM STRESS; MULTIPLE-MYELOMA CELLS; BK CHANNEL ACTIVITY; MENTAL-RETARDATION; THALIDOMIDE TERATOGENICITY; CONFORMATIONAL DEFECT; POTASSIUM CHANNEL;
D O I
10.1007/s00424-016-1854-1
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Cereblon (CRBN) is a substrate receptor of the E3 ubiquitin ligase complex that has been linked to autosomal recessive non-syndromic mental retardation. Several key findings suggest diverse roles of CRBN, including its regulation of the large-conductance calcium- and voltage-activated potassium (BKCa) channels, regulation of thalidomide-binding proteins, and mediation of lenalidomide treatment in multiple myeloma. Recent studies also indicate that CRBN is involved in energy metabolism and negatively regulates AMP-activated protein kinase signaling. Mice with genetic depletion of CRBN are resistant to various stress conditions including a high-fat diet, endoplasmic reticulum stress, ischemia/reperfusion injury, and alcohol-related liver damage. In this review, we discuss the various roles of CRBN in human health and disease and suggest avenues for further research to enhance our basic knowledge and clinical application of CRBN.
引用
收藏
页码:1299 / 1309
页数:11
相关论文
共 83 条
  • [21] Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity
    Gandhi, Anita K.
    Mendy, Derek
    Waldman, Michelle
    Chen, Gengxin
    Rychak, Emily
    Miller, Karen
    Gaidarova, Svetlana
    Ren, Yan
    Wang, Maria
    Breider, Michael
    Carmel, Gilles
    Mahmoudi, Afshin
    Jackson, Pilgrim
    Abbasian, Mahan
    Cathers, Brian E.
    Schafer, Peter H.
    Daniel, Tom O.
    Lopez-Girona, Antonia
    Thakurta, Anjan
    Chopra, Rajesh
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (02) : 233 - 244
  • [22] Treating chronic lymphocytic leukemia with thalidomide and lenalidomide
    Giannopoulos, Krzysztof
    Mertens, Daniel
    Stilgenbauer, Stephan
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (18) : 2857 - 2864
  • [23] High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone
    Heintel, Daniel
    Rocci, Alberto
    Ludwig, Heinz
    Bolomsky, Arnold
    Caltagirone, Simona
    Schreder, Martin
    Pfeifer, Sabine
    Gisslinger, Heinz
    Zojer, Niklas
    Jaeger, Ulrich
    Palumbo, Antonio
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (05) : 695 - 700
  • [24] Glutamine and cancer: cell biology, physiology, and clinical opportunities
    Hensley, Christopher T.
    Wasti, Ajla T.
    DeBerardinis, Ralph J.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (09) : 3678 - 3684
  • [25] A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation
    Higgins, JJ
    Pucilowska, J
    Lombardi, RQ
    Rooney, JP
    [J]. NEUROLOGY, 2004, 63 (10) : 1927 - 1931
  • [26] Dysregulation of large-conductance Ca2+-activated K+ channel expression in nonsyndromal mental retardation due to a cereblon p.R419X mutation
    Higgins, Joseph J.
    Hao, Jin
    Kosofsky, Barry E.
    Rajadhyaksha, Anjali M.
    [J]. NEUROGENETICS, 2008, 9 (03) : 219 - 223
  • [27] Temporal and Spatial Mouse Brain Expression of Cereblon, An Ionic Channel Regulator Involved in Human Intelligence
    Higgins, Joseph J.
    Tal, Adit L.
    Sun, Xiaowei
    Hauck, Stefanie C. R.
    Hao, Jin
    Kosofosky, Barry E.
    Rajadhyaksha, Anjali M.
    [J]. JOURNAL OF NEUROGENETICS, 2010, 24 (01) : 18 - U33
  • [28] Cereblon is expressed in the retina and binds to voltage-gated chloride channels
    Hohberger, Bettina
    Enz, Ralf
    [J]. FEBS LETTERS, 2009, 583 (04): : 633 - 637
  • [29] Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
    Huang, Shang-Yi
    Lin, Chung-Wu
    Lin, Hsiu-Hsia
    Yao, Ming
    Tang, Jih-Luh
    Wu, Shang-Ju
    Chen, Yao-Chang
    Lu, Hsiao-Yun
    Hou, Hsin-An
    Chen, Chien-Yuan
    Chou, Wen-Chien
    Tsay, Woei
    Chou, Sheng-Je
    Tien, Hwei-Fang
    [J]. ANNALS OF HEMATOLOGY, 2014, 93 (08) : 1371 - 1380
  • [30] Identification of a Primary Target of Thalidomide Teratogenicity
    Ito, Takumi
    Ando, Hideki
    Suzuki, Takayuki
    Ogura, Toshihiko
    Hotta, Kentaro
    Imamura, Yoshimasa
    Yamaguchi, Yuki
    Handa, Hiroshi
    [J]. SCIENCE, 2010, 327 (5971) : 1345 - 1350